Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation.

Chapman R, Rybicki EP.

Vaccines (Basel). 2019 Jun 13;7(2). pii: E50. doi: 10.3390/vaccines7020050. Review.

2.

CRISPR-Cas9 strikes out in cassava.

Rybicki EP.

Nat Biotechnol. 2019 Jun 13. doi: 10.1038/s41587-019-0169-0. [Epub ahead of print] No abstract available.

PMID:
31197230
3.

Immunogenicity of plant-produced porcine circovirus-like particles in mice.

Gunter CJ, Regnard GL, Rybicki EP, Hitzeroth II.

Plant Biotechnol J. 2019 Feb 21. doi: 10.1111/pbi.13097. [Epub ahead of print]

4.

Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.

van Diepen MT, Chapman R, Douglass N, Galant S, Moore PL, Margolin E, Ximba P, Morris L, Rybicki EP, Williamson AL.

J Virol. 2019 Apr 3;93(8). pii: e02155-18. doi: 10.1128/JVI.02155-18. Print 2019 Apr 15.

5.

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256.

van Diepen MT, Chapman R, Moore PL, Margolin E, Hermanus T, Morris L, Ximba P, Rybicki EP, Williamson AL.

PLoS One. 2018 Dec 17;13(12):e0208310. doi: 10.1371/journal.pone.0208310. eCollection 2018.

6.

Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.

Mbewana S, Meyers AE, Weber B, Mareledwane V, Ferreira ML, Majiwa PAO, Rybicki EP.

BMC Biotechnol. 2018 Dec 11;18(1):77. doi: 10.1186/s12896-018-0489-z.

7.

Chimaeric Rift Valley Fever Virus-Like Particle Vaccine Candidate Production in Nicotiana benthamiana.

Mbewana S, Meyers AE, Rybicki EP.

Biotechnol J. 2019 Apr;14(4):e1800238. doi: 10.1002/biot.201800238. Epub 2018 Dec 18.

PMID:
30488669
8.

Minimally processed crude leaf extracts of Nicotiana benthamiana containing recombinant foot and mouth disease virus-like particles are immunogenic in mice.

Ruiz V, Baztarrica J, Rybicki EP, Meyers AE, Wigdorovitz A.

Biotechnol Rep (Amst). 2018 Sep 28;20:e00283. doi: 10.1016/j.btre.2018.e00283. eCollection 2018 Dec.

9.

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses.

Dennis SJ, O'Kennedy MM, Rutkowska D, Tsekoa T, Lourens CW, Hitzeroth II, Meyers AE, Rybicki EP.

Vet Res. 2018 Oct 11;49(1):105. doi: 10.1186/s13567-018-0600-4.

10.

Transient expression of heat- and acid-resistant foot-and-mouth disease virus P1-2A mutants in Nicotiana benthamiana.

Veerapen VP, van Zyl AR, Rybicki EP, Meyers AE.

Virus Res. 2018 Sep 2;256:45-49. doi: 10.1016/j.virusres.2018.08.004. Epub 2018 Aug 4.

PMID:
30086326
11.

Distinct Oceanic Microbiomes From Viruses to Protists Located Near the Antarctic Circumpolar Current.

Flaviani F, Schroeder DC, Lebret K, Balestreri C, Highfield AC, Schroeder JL, Thorpe SE, Moore K, Pasckiewicz K, Pfaff MC, Rybicki EP.

Front Microbiol. 2018 Jul 17;9:1474. doi: 10.3389/fmicb.2018.01474. eCollection 2018.

12.

Optimizing a Human Papillomavirus Type 16 L1-Based Chimaeric Gene for Expression in Plants.

Hitzeroth II, Chabeda A, Whitehead MP, Graf M, Rybicki EP.

Front Bioeng Biotechnol. 2018 Jul 16;6:101. doi: 10.3389/fbioe.2018.00101. eCollection 2018.

13.

Production of complex viral glycoproteins in plants as vaccine immunogens.

Margolin E, Chapman R, Williamson AL, Rybicki EP, Meyers AE.

Plant Biotechnol J. 2018 Jun 11. doi: 10.1111/pbi.12963. [Epub ahead of print] Review.

14.

Characterization of the hypersensitive response-like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathway.

Kim BM, Lotter-Stark HCT, Rybicki EP, Chikwamba RK, Palmer KE.

Plant Biotechnol J. 2018 Oct;16(10):1811-1821. doi: 10.1111/pbi.12917. Epub 2018 May 2.

15.

Transient Expression and Purification of Horseradish Peroxidase C in Nicotiana benthamiana.

Huddy SM, Hitzeroth II, Meyers AE, Weber B, Rybicki EP.

Int J Mol Sci. 2018 Jan 1;19(1). pii: E115. doi: 10.3390/ijms19010115.

16.

Therapeutic vaccines for high-risk HPV-associated diseases.

Chabeda A, Yanez RJR, Lamprecht R, Meyers AE, Rybicki EP, Hitzeroth II.

Papillomavirus Res. 2018 Jun;5:46-58. doi: 10.1016/j.pvr.2017.12.006. Epub 2017 Dec 19. Review.

17.

Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.

Veerapen VP, van Zyl AR, Wigdorovitz A, Rybicki EP, Meyers AE.

Virus Res. 2018 Jan 15;244:213-217. doi: 10.1016/j.virusres.2017.11.027. Epub 2017 Dec 1.

PMID:
29196195
18.

Complete Genome Sequence of Bos taurus Papillomavirus Type 1, Isolated in Morocco.

Regnard GL, Matiso A, Mounir L, Embarki T, Hitzeroth II, Rybicki EP.

Genome Announc. 2017 Sep 21;5(38). pii: e00979-17. doi: 10.1128/genomeA.00979-17.

19.

Recombinant expression of beak and feather disease virus capsid protein and assembly of virus-like particles in Nicotiana benthamiana.

Regnard GL, Rybicki EP, Hitzeroth II.

Virol J. 2017 Sep 11;14(1):174. doi: 10.1186/s12985-017-0847-9.

20.

Xenogenic rolling-circle replication of a synthetic beak and feather disease virus genomic clone in 293TT mammalian cells and Nicotiana benthamiana.

Regnard GL, de Moor WRJ, Hitzeroth II, Williamson AL, Rybicki EP.

J Gen Virol. 2017 Sep;98(9):2329-2338. doi: 10.1099/jgv.0.000915.

PMID:
28885140

Supplemental Content

Loading ...
Support Center